HOME >> BIOLOGY >> NEWS
Increased bone mass in a calcitonin knockout mouse full of surprises

Find below one highlighted articles and the full Table of Contents for the December 16 issue.

****************************************************

Increased bone mass in a calcitonin knockout mouse full of surprises

Bone is in a constant state of remodeling, during which osteoclasts remove old bone (resorption) and osteoblasts form new bone (formation). Calcitonin is a hormone produced by the thyroid gland and inhibits bone resorption. Following menopause, the rate of bone loss is accelerated, however women with post-menopausal osteoporosis that are treated with calcitonin (by injection or nasal spray) demonstrate increased bone mass and strength, in addition to a decrease in the rate of bone fractures. Following alternative processing, the gene encoding calcitonin (CT/CGRP) also encodes a second peptide: calcitonin gene-related peptide-a (CGRPa), however the role of this peptide in bone metabolism has not been clearly defined.

To better understand the role of calcitonin and CGRP-a in bone metabolism Robert Gagel and colleagues at the University of Texas M.D. Anderson Cancer Center, USA, created mice in which the CT/CGRP gene had been deleted. Given that both calcitonin and CGRP have been shown to inhibit bone resorption and CGRP is known to stimulate bone formation, the authors predicted that there would be either no effect of this deletion on bone mass, or there could be some bone loss.

In the December 16 issue of the Journal of Clinical Investigation, the authors report their surprising finding that CT/CGRP-deficient mice have greater bone mass, increased bone formation, and were able to maintain bone mass during estrogen deficiency by increasing bone formation. These findings suggest an important and novel function for the products of the CT/CGRP gene, that was previously unrecognized. They also suggest that the development of an antagonist to the CT/CGRP gene product(s)
'"/>

Contact: Brooke Grindlinger, Ph.D.
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
17-Dec-2002


Page: 1 2

Related biology news :

1. Increased atmospheric carbon dioxide promotes algal growth
2. Increased temperature may prevent winter flounder from rebounding in east coast estuaries
3. Get your blood moving: Increased blood flow could lead to healthier blood vessels
4. Increased fiber curbs appetite in women
5. Increased CO2 levels are mixed blessing for agriculture
6. Increased awareness of stroke symptoms could dramatically reduce stroke disability
7. Increased use of chemicals in agriculture worldwide seen as major environmental threat
8. Increased consumption of soy protein may help lower cholesterol
9. Increased consumption of whole grain foods associated with decreased risk of stroke
10. Increased risk of wheeze and asthma in young children whose mothers smoke during the pregnancy
11. Increased production of antibiotics in space reported by University of Colorado researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech , ... dialogue, today announces its inaugural South CEO conference to be held ... , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to discuss ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... ... its technology driven portfolio of 3D porous titanium spinal implants with the expansion ... Ti3D implant offerings while more than tripling the number of cervical and lumbar ...
(Date:9/22/2019)... ... September 20, 2019 , ... ... are adjusting to client demands for precision medicine products. The report, Lab ... $19 billion in 2018, the pharma/bio sector is the largest source of demand ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... VEGAS (PRWEB) , ... October 10, 2019 , ... R3 ... courses. The next course is October 18-19th, 2019 in Las Vegas with spots still ... exosomes. He completed training at several Ivy League universities including Cornell, Harvard and Dartmouth. ...
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, ... announced the midway point of its randomized research trial for individuals with persisting ... measure the efficacy of a non-invasive technology which compares tones delivered to a ...
(Date:10/3/2019)... Ontario (PRWEB) , ... October 02, 2019 , ... ... sequencing using mass spectrometry, is pleased to announce that it has moved into ... spectrometers among other analytical instruments, the new facility demonstrates the company's continuous commitment ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and ... company focused on the development of therapies to treat central nervous system ...
Breaking Biology Technology:
Cached News: